Mineralys Therapeutics (MLYS) News
NASDAQ: MLYSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
23.37+0.99 (+4.42%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MLYS news summary
We found 2 recent headlines mentioning Mineralys Therapeutics (MLYS): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, MLYS is up 4.42% at $23.37. The most recent story, "Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026", was published by GlobeNewswire on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Mineralys Therapeutics headlines
- Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026- New analyses from the pivotal Launch-HTN trial showed that 46% of participants with difficult-to-treat hypertension receiving lorundrostat 50 mg achieved the AHA/ACC Guideline systolic blood…GlobeNewswire
- After-Hours Earnings Report for August 11, 2026 : LITE, FNV, CRWV, SMCI, CAVA, IFS, HRB, FLY, MLYS, NN, TGLS, TSHAThe following companies are expected to report earnings after hours on 08/11/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Lumentum Holdings Inc. (LITE)is reporting…NasdaqLITE, FNV, CRWV, SMCI